Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy
Go back to Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy| Novaterra Corp Unclassified (AMEX: NVTA) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $11.85 | |||
| Open | $0.25 | 52 Week Low | $5.66 | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $0.00 | |||
| Volume | 122,861 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.26 | 52 Week High | $63.73 | |||
| Open | $17.26 | 52 Week Low | $8.00 | |||
| Day High | $17.26 | P/E | N/A | |||
| Day Low | $17.26 | EPS | $-5.69 | |||
| Volume | 3,935 | |||||
